Table 1 Clinical characteristics of the subjects of this study
Variables | Total (n = 1160) | Controls (n = 351) | T2DM patients (n = 431) | T2DM complicated with CAD patients (n = 378) | p values |
|---|---|---|---|---|---|
Age, years | Â | Â | Â | Â | Â |
< 60, n(%) | 497(42.8) | 219(62.4) | 177(41.1) | 101(26.7) | < 0.001 |
≥ 60, n(%) | 663(57.2) | 132(37.6) | 254(58.9) | 277(73.3) | |
Gender | Â | Â | Â | Â | Â |
Male, n(%) | 754(65.0) | 226(64.4) | 285(66.1) | 243(64.3) | 0.831 |
Female, n(%) | 406(35.0) | 125(35.6) | 146(33.9) | 135(35.7) | |
BMI (kg/m2) | Â | Â | Â | Â | Â |
< 18.5 | 128(11.0) | 94(26.8) | 15(3.5) | 19(5.0) | < 0.001 |
18.5–23.9 | 613(52.8) | 197(56.1) | 217(50.3) | 199(52.6) | |
≥ 24.0 | 419(36.1) | 60(17.1) | 199(46.2) | 160(42.3) | |
History of smoking, n(%) | 245(21.1) | 66(18.8) | 92(21.3) | 87(23.0) | 0.376 |
History of alcoholism, n(%) | 58(5.0) | 23(6.6) | 17(3.9) | 18(4.8) | 0.243 |
Serum lipid-lipoprotein levels | Â | Â | Â | Â | Â |
TC, mmol/L | 4.47 ± 1.30 | 4.23 ± 1.15 | 4.56 ± 1.42 | 4.60 ± 1.26 | < 0.001 |
TG, mmol/L | 1.81 ± 1.63 | 1.33 ± 0.79 | 1.95 ± 1.86 | 2.10 ± 1.83 | < 0.001 |
HDL-C, mmol/L | 1.12 ± 0.36 | 1.17 ± 0.43 | 1.07 ± 0.32 | 1.12 ± 0.31 | 0.001 |
LDL-C, mmol/L | 2.45 ± 0.86 | 2.36 ± 0.77 | 2.52 ± 0.90 | 2.46 ± 0.88 | 0.023 |
Apo-A1, g/L | 1.03 ± 0.27 | 1.01 ± 0.32 | 1.01 ± 0.26 | 1.05 ± 0.23 | 0.046 |
Apo-B, g/L | 0.80 ± 0.25 | 0.75 ± 0.23 | 0.83 ± 0.26 | 0.82 ± 0.26 | < 0.001 |